Hsiang-I Tsai

5PUBLICATIONS
23CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyNanophotonicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 07, 2025
ABCC10-mediated cGAMP efflux drives cancer cell radiotherapy resistance.

Zhengyang Zhang, Jie Gao, Xiang Liao

|Jun 26, 2025
Discoidin Domain Receptors in Tumor Biology and Immunology: Progression and Challenge.

Heng Zhang, Wenlong Chen, Haitao Zhu

|Feb 08, 2021
NF45/NF90-mediated rDNA transcription provides a novel target for immunosuppressant development.

Hsiang-I Tsai, Xiaobin Zeng, Longshan Liu

|Dec 28, 2020
PD-L1 cellular nanovesicles carrying rapamycin inhibit alloimmune responses in transplantation.

Min Yang, Zhanxue Xu, Hailan Yan

Pageof 1